Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

The 'most notable' opportunity for pharmacy owners to capitalise upon in 2024 revealed

The 'most notable' opportunity for pharmacy owners to capitalise upon in 2024 revealed

Overall, pharmacy goodwill prices are anticipated to remain consistent in the coming months 

Pharmacy sales specialist, Hutchings Consultants has revealed its market predictions for the next 12 months in a new report.


The broker is anticipating that both independent group operators and corporate owners will continue to reassess their existing portfolios in 2024, making strategic disposals of varying sizes.

“This is likely to result in transaction volumes remaining high for the foreseeable future,” stated the report authored by Paul Steet, Associate Director, Hutchings Consultants.

Community Pharmacy Contractual Framework negotiations will be the most notable opportunity for the sector to capitalise upon this year, the broker said, adding that it’s “a belated opportunity for the sector to secure a vital uplift to the contract’s fixed global sum.”

The launch of Pharmacy First Scheme in England is seen as a positive development, as Paul said it offers “a much-needed financial boost” to the sector.

He said that the new scheme and the recent announcement of a 5% funding increase in Wales are “already bringing a renewed degree of confidence from buyers as we move into 2024.”

Additionally, the broker has anticipated some reduction in interest rates by the Bank of England in coming months, relieving the financial pressure felt by existing operators to certain extent and assisting buyers with affordability.

Overall, pharmacy goodwill prices are expected to remain consistent during the year unless “the supply of pharmacies on the market falls further or a more significant uplift in community pharmacy funding is secured.”

Hutchings encourages pharmacy owners to focus on their drug buying and profit margin through 2024 as “this is such a key factor for pharmacy goodwill values.”

A look back at 2023

Hallo Healthcare Group’s decision to divest their portfolio of over 1,054 Lloyds Pharmacies resulted in an unprecedented increase in the number of business opportunities on the UK pharmacy market in initial six months of 2023.

The divestment created a “fever-pitch level” of demand from potential buyers both within the market and outside, according to the Hutchings report.

In Scotland alone, Lloyd’s disposals resulted in a massive 533 per cent increase in completed deals at Hutchings.

Although on a significantly smaller scale, Boots and Well also opted to divest some branches, with the former announcing its plan to axe 300 branches around the UK.

Existing pharmacy owners with single branches completed most corporate acquisitions last year, while first-time buyers acquired the majority of the independent sales, according to the broker.

Hutchings saw a significant increase in the number of enquiries and registrations from both new and existing buyers for pharmacy triggered by large-scale corporate disposals in 2023.

In 2023, the number of new buyer registrations increased over 90 per cent, compared to the previous year.

At 77 per cent, first-time buyers accounted for the majority of the new registrations, followed by existing owners at 15 per cent.

Almost all sales the broker transacted last year involved the buyer obtaining a bank loan.

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less